Therapeutic Expertise

Crafting a genomics strategy early is key for successful oncology drug development

Rare Disease factsheet

Venturing into a new era of CNS drug development to improve success

Three strategies that apply multidisciplinary solutions earlier in the development process to reduce failures and accelerate CNS drug development.

FOUR TRENDS THAT WILL GUIDE THE FUTURE OF DRUG DEVELOPMENT IN ONCOLOGY

CAR T-Cell Therapies Pose A New Development Model and Demand New Skill Sets

Rare Disease Infographic

Managing rare disease studies requires a very different approach.

Challenging Conventional Patient Recruitment And Care Strategies For Rare Disease Studies

Read this article to find out more about orphan diseases.

Three Important Considerations of Cardiovascular Outcomes Trials

Infographic:Consider these three important strategies prior to conducting Cardiovascular Outcomes Trials.

Faster Is The New Normal In Oncology Drug Development

Learn five risk-mitigation strategies to produce data-rich trials, better teamwork and more regulatory interaction.

Behind the Breakthrough: How the FDAs Breakthrough Designation Changes a Trial

Learn more about the most coveted of expedited pathways.

The Past Present and Future of Cancer Immunotherapy

Learn five strategies for accelerating future successes in cancer immunotherapy.

Starting Stronger In Phase I Through IIA

From First-in-Human (FiH) through Proof-of-Concept (PoC), our Early Phase Services help you set a solid foundation so that you have a better chance of achieving success.

Challenging Conventional Patient Recruitement and Care Strategies for Orphan Disease Studies

Challenge conventional patient recruitment methods and care strategies to successfully recruit patients for orphan disease studies.

Accelerated Pathways: Global Opportunities and Challenges for Innovators

Navigate the opportunities and challenges accelerated pathways present with these key strategies.

World Class Early Phase Clinical Units:Infographic

Global Capabilities to Ensure Your Study’s Efficiency, Quality and Safety.

London EPCU Fact Sheet

Highest level of accreditation from the UK Medicines and Healthcare Regulatory Agency for Phase I clinical study units to carry out studies with compounds at all levels of risk.

Berlin EPCU Fact Sheet

In-house scientific and medical expertise, combined with the latest in clinical and research technology.

Los Angeles EPCU Fact Sheet

One of the world’s largest Japanese Phase I units. Pioneered the conduct of Asian (Japanese, Chinese and Korean) ethnobridging studies outside of Asia in 2001.